Topline data from CHAPTER-3, a pivotal study of deucrictibant for prophylactic treatment of HAE attacks, anticipated in 3Q2026Preparation of NDA dossier of deucrictibant for on-demand treatment of HAE ...

Rail Vision Ltd. (Nasdaq: RVSN) ('Rail Vision” or the 'Company”), an early commercialization stage technology company seeking ...

It’s easy to dismiss the Portrait of a Graduate phenomenon as a relatively innocuous exercise that will probably fade away ...

Book, Line and Thinker | 2026 has begun with accelerating geopolitical upheaval and deepening economic discontent, setting ...